the X chromosome. 7 Thus, other genetic and/or epigenetic cell lymphomas, thymic lymphomas induced in either
affected by the Moloney helper virus. 6, 8, 14 This is consistent with the observation that A-MuLV/M-induced thymomas do not demonstrate virus integration in sites that are frequently Introduction occuped by provirus in Mo-MuLV-induced thymomas.
14 Therefore, if other genetic events are required for clonal selecThe v-abl oncogene of the Abelson murine leukemia virus (Ation of A-MuLV-infected cells in these examples, these events MuLV) encodes a 160 kDa gag-abl tyrosine kinase that acutely may not include altered gene expression due to proviral intetransforms pre-B lymphocytes when inoculated into suscepgration. tible mice, or when used to transform long-term bone marrow
The human bcr-abl oncogene that is expressed from the Phicultures (reviewed in Ref. 1) . A-MuLV can also transform ladelphia chromosome encodes constitutively active p210 or immature T lymphoid cells when injected intrathymically. [2] [3] [4] p185 tyrosine kinases (reviewed in Ref. 16 ). Retroviral Although many cells in these lymphoid populations are expression models have shown that bcr-abl, like v-abl, transinitially infected by A-MuLV, the resultant malignancies are forms pre-B lymphocytes in long-term bone marrow culclonal or oligoclonal in origin. 5, 6 Furthermore, early after ture, [17] [18] [19] and transforms immature T cells after intrathymic infection, v-abl transformed clones are poorly oncogenic, but injection. 2 However, compared to cells transformed by Aover time, highly malignant variants emerge. [5] [6] [7] [8] [9] [10] [11] Together, MuLV, bcr-abl virus-transformed B and T cells appear after these observations demonstrate that infected populations a significantly longer latency 2, 18 and do not progress to full undergo a clonal selection in which only one or two infected transformation as quickly. 18 Also, compared to A-MuLV, bcrcells progress to a fully oncogenic phenotype. We have abl viruses are less efficient at transforming fibroblasts in reported that this oncogenic progression of v-abl transformed vitro 20 and pre-B cells in vivo. 18 In sum, bcr-abl is a signifilymphoblasts is associated with non-random cytogenetic cantly weaker oncogene than v-abl. 21 Therefore, knowing that changes involving deletion of a common region of murine cells transformed by the more potent v-abl oncogene can chromosome 13, appearance of an additional chromosome 5, require other genetic or epigenetic events to achieve full transand/or other abnormalities involving a common breakpoint on formation, it is reasonable to think that the oncogenic pheno 
Thymic lymphomas
The thymic lymphomas examined in this report have been Results previously described. We previously reported that intrathymic injection of bcrabl/M, A-MuLV/M, and Mo-MuLV gives rise to thymic lymble levels of the respective oncogene-expressing defective virus as determined by immunoblot analysis of abl oncophomas that can be distinguished by the latency of tumor development, the pattern of disease, and by oncogene proteins in acutely infected NIH 3T3 fibroblasts. 18 The pathogenesis, molecular and phenotypic characterization of expression. 2 Data in Figure 1 show that the kinetics of tumor development also is different in mice injected with the differthe thymic lymphomas have been previously reported. (Figure 1 ). About 30-High molecular weight DNA extracted from primary thymomas was analyzed by Southern blot for rearrangements in 50% of the animals injected with a bcr-abl/M virus developed T lymphoid thymic tumors which did not carry the bcr-abl five loci, c-myc, N-myc, Mlvi-1 (Mis-1/pvt-1), Pim-1, and Ahi-1, that have been reported to serve as common sites of viral provirus 2 but did carry Moloney-related proviral DNA (see below). These tumors developed with a latency and gross integration in murine T or B cell lymphomas. Since, in most cases, only one restriction enzyme and one hybridization pathology that was characteristic of Mo-MuLV-induced thymomas, and, therefore, were of Mo-MuLV origin. 2 probe were used to detect rearrangement at each locus, some rearrangements might have been missed due to coincidental Southern blot analysis of the junctions between cellular and proviral DNA, and of Igh and Tcr gene structure demonstrated migration of a rearranged band with the germline fragment, or because rearrangements occurred outside of the regions that thymomas induced with each virus were clonal or oligoclonal in origin. 2 The relative proviral content of each tumor tested. These studies, therefore, provide only a minimal estimate of the number of rearrangements present in these five was measured from the Southern blots as the ratio of the intensity of the v-abl or bcr-abl proviral band to the intensity of the loci.
Thymoma DNAs were digested with restriction enzymes germline c-abl band. This showed that the proviral content in each A-MuLV/M and bcr-abl/M tumor was comparable to the reported by other investigators to detect rearrangements in the five test loci. For initial analysis of the Pim-1 and Ahi-1 loci, relative proviral content of clonal A-MuLV or bcr-abl-transformed pre-B cell lines. 
Thymomas induced with the different viruses contain multiple proviral integrations
In order to compare the number of proviruses integrated into the genome of tumors induced with the different viruses, DNA from the primary thymomas was digested with EcoRI, and hybridized with the ecotropic Moloney U3 LTR probe. While EcoRI does not cut within either A-MuLV or Mo-MuLV genomes, it does cut with the bcr-abl virus and within the recom- The data presented in Table 1 , give an impression that Table 1 were analyzed to compare the incidence one of the four test loci the data were also analyzed by com-
paring the total number of loci that were rearranged in each
group. This analysis revealed a significant difference in the
overall frequency of involvement of these four loci between in A-MuLV/M transformed pre-B cells. 15 In all previously ND, not done.
reported cases, an ecotropic provirus was always integrated in the same orientation relative to Ahi-1 and no evidence was and BamHI sites at 2.8 and 6.2 kb, respectively, upstream of the reference EcoRV site that lies immediately 3′ of the probe, found for the presence of recombinant MuLV in the pre-B lymphomas. 15 To determine the site and type of proviral intep2-1 (Figure 3b) . No rearrangement was detected in the downstream Pst1 site. Restriction analysis further revealed a novel gration in the Ahi-1 region of the thymic lymphomas, tumor DNA was digested with enzymes that cut asynchronously 8.6 kb EcoRI fragment (Figure 3a ) which did not co-migrate with the 14 kb v-abl-specific EcoRI fragment reported prewithin the Mo-MuLV genome and hybridized with the Ahi-1 probe, p2-1, that maps close to the common proviral inteviously for this tumor. 2 Together, these data are consistent with the presence of a recombinant MuLV inserted approxigration sites found in pre-B cell lymphomas. 15 A representative example of this analysis is shown in Figure 3 for tumors mately 2.7 kb upstream of the reference EcoRV site in the Ahi-1 region, (Figure 3b ). A15.7 and M11.10, both of which consisted of Ͼ90% T lymphocytes. 2 For tumor A15.7, novel 2.8 kb EcoRV and 8.5 kb A similar strategy was used to analyze thymoma M11.10. In this case, the analysis revealed novel 11.3 kb EcoRV, 9.3 kb BamHI fragments were detected in addition to the normal 12 kb and 11 kb germline fragments. The sizes of the PstI, and 10 kb BamHI bands. In contrast, digestion with EcoRI did not reveal any novel bands. These data are consistent with rearranged fragments indicated the presence of new EcoRV insertion of an MuLV between the EcoRI and EcoRV restriction it would not be surprising to find that Pim-1 plays an sites immediately downstream of the p2-1 probe. Because the important role in bcr-abl transformation. Our observations EcoRI digestion was uninformative in this analysis, it cannot also raise the possibility that retroviral integration in the Mlvibe determined whether the provirus inserted within this region 1 locus may confer a selective advantage in bcr-abl-expressrepresents an ecotropic or recombinant MuLV.
ing cells. Mlvi-1 was originally identified as a common retroThe approximate sites of proviral integrations near Ahi-1 in viral integration site in Mo-MuLV-induced thymomas and subtumors M5.2 and M14.16 are also indicated in Figure 3b . In sequently found to be identical to two independently tumor M5.2, detection of a novel EcoRI site suggested the identified loci, the common proviral integration locus (Mispresence of a recombinant MuLV while EcoRI digestion for 1) 42 and a locus involved in the 6;15 variable translocation tumor M14.6 was uniformative and the type of retrovirus in mouse plasmacytomas (Pvt-1). [43] [44] [45] The Mlvi-1/Mis-1/Pvt-1 inserted within the Ahi-1 region cannot be determined.
locus has been mapped almost 300 kb 3′ of c-myc. 43 Another viral integration site (Mlvi-4) was mapped within this region between c-myc and Mlvi-1. 46 Viral insertions in Mlvi-1 and Discussion
Mlvi-4 induce expression of nearby genes and cause long distance activation of c-myc expression. 46 Thus, the DNA region In an initial effort to understand whether proviral activation of between c-myc and Mlvi-1 represents a domain of coordicellular genes might play a role in thymomas induced by bcrnately regulated genes that can be activated by perturbations abl/M virus, we tested the hypothesis that the pattern of mediated by provirus integration or by other chromosomal proviral integration in bcr-abl/M-induced thymomas would events. 46, 47 If recurring proviral integration leads to activation overlap with the pattern of proviral integration in thymic of these different proto-oncogenes, this would be consistent lymphomas induced with Moloney virus alone. On the other with the multi-step model of bcr-abl transformation. hand, if, as with transformation by A-MuLV/M, proviral inteOur observation of proviral integration near the Ahi-1 locus gration does not affect bcr-abl/M-induced thymomagenesis, in the T cell tumors was unexpected since it was previously we would not expect to detect proviral integration in these reported that Ahi-1 is occupied by provirus only in B cell lymloci. As predicted, thymomas induced with A-MuLV/M did not phomas induced with A-MuLV/M and not in Moloney virusdisplay frequent rearrangement in the test loci; however, induced thymomas. 15 It is not clear why our observations conrecurring occupancy of Pim-1, c-myc and Mlvi-1 loci was tradict previous reports; however, it is possible that different observed in both Mo-MuLV and bcr-abl/M-induced thymroutes of injection of the retroviruses (intrathymic vs systemic) omas. The fact that we found similar levels of bcr-abl proviral may somehow alter the pathogenesis and thereby affect the DNA in a clonal pre-B cell line as well as in the thymic tumors pattern of proviral integration in the emerging tumor. Furtherfrom different animals 2 indicates that cells transformed only more, we used a different strain and age of mice than used by Moloney virus contributed little to the bcr-abl/M-induced previously which also could affect viral pathogenesis. 48, 49 thymic lymphomas. Furthermore, tumors induced by intraAlthough Ahi-1 has been assigned to mouse chromosome 10, thymic injection of Mo-MuLV alone developed extensive perand maps approximately 35 kb downstream of the c-Myb ipheral lymphomas with relatively little involvement of the gene, there is no evidence for activation of c-Myb in B cell thymus, whereas tumors induced with the bcr-abl oncogene developed a prominent thymic lymphoma with minimal perlymphomas containing provirus integrated within Ahi-1. 50 For ipheral disease. 2 Thus, Mo-MuLV-transformed cells, if present, this reason it has been concluded that provirus insertion in would not be expected to represent a significant population Ahi-1 affects an unknown gene in pre-B lymphomas. Our in bcr-abl/M tumors. Therefore, it is unlikely that the observed observations raise the possibility that proviral activation of this rearrangement of these loci in bcr-abl/M-transformed thymic unknown gene may also play a role in Moloney and Abelson lymphomas is due to the presence in the same tumor of separvirus-induced T cell lymphomas in BALB/c mice. ate populations of cells transformed with Moloney virus vs
Results presented here also suggest that c-myc, N-myc, Pimbcr-abl/M virus.
1 and Ahi-1 loci may be occupied at a lower frequency in Knowing that the chicken genome contains several hundred bcr-abl/M-induced thymomas compared to Mo-MuLV tumors. highly preferred viral integration sites, 38 it is likely that the Therefore, the repertoire of loci commonly occupied by promouse genome also carries a very large number of potential virus in thymomas induced with the different viruses may not regions of viral integration. Therefore, the observation of completely overlap. This could mean that oncogenic prorecurring proviral integration in Pim-1, c-myc and Mlvi-1 loci gression in thymomas that express the bcr-abl tyrosine kinase in Mo-MuLV and bcr-abl/M-induced tumors probably reflects may result from the selection of activated genes that are capa selective advantage conferred by proviral occupation of able of synergizing with the bcr-abl kinase, while progression these loci. If this model is correct, it suggests that proviral actiof tumors induced with Mo-MuLV alone may result from the vation of cellular proto-oncogenes can affect the pathogenesis selection of infected cells in which a different set of genes of bcr-abl-induced thymomas. Since ectopic expression of care activated. myc facilitates transformation of hematopoietic cells by bcrIn summary, this report presents evidence that proviral abl, 24 this model predicts that recurring proviral integration insertion in common integration sites is a frequent event in would likely be found near c-myc in bcr-abl/M thymomas.
thymomas induced with bcr-abl/M viruses. We suggest that Furthermore, the observed proviral integration near Pim-1 this may result in activation of cellular genes that can facilitate raises the possibility that activation of this gene may also oncogenic transformation by the weak bcr-abl oncogene. If facilitate bcr-abl transformation. Cooperation between bcr-abl true, then this thymic transformation model may provide an and Pim-1 has not been previously demonstrated; however, important tool for identifying other genes that can influence the Pim-1-encoded serine kinase is an integral part of downthe pathogenesis of hematopoietic malignancies initiated by stream signaling from IL-2, IL-3 and GM-CSF receptors. [39] [40] [41] bcr-abl. Since expression of v-abl and bcr-abl kinases enables cells to survive and proliferate in the absence of these growth factors, 
